Diabetic Retinopathy News and Research

RSS
In the initial stages, people with diabetic retinopathy may not notice their vision changing. Diabetics sometimes experience rapid changes in blood sugar that can temporarily cause blurry vision even when retinopathy is not present. If a person notices a few specks or spots floating in his visual field, this may mean he has developed proliferative diabetic retinopathy, the growth of abnormal new blood vessels on the retina and optic nerve. High blood sugar levels have been linked in studies to retinal blood vessel abnormalities. Blurred vision may occur when the macula--the small area at the center of the retina--swells as it fills with fluid that has leaked from retinal blood vessels. Because damage to the eye often develops slowly, early detection of diabetes and control of blood sugar through diet and medications can make a crucial difference in saving vision.

Effective diabetic retinopathy treatments include laser photocoagulation for early to moderate stages and a microsurgery called vitrectomy for repair of eyes with extensive damage. Injectable and oral medications that act on abnormal blood vessels to control diabetic retinopathy before vision loss occurs are now in development. Early detection would be key to the effectiveness of these treatments, also.
Research may lead the way toward new treatments for proliferative retinopathies

Research may lead the way toward new treatments for proliferative retinopathies

SIFI, NovaMedica agree to market eight products for treatment of ophthalmic pathologies in Russia

SIFI, NovaMedica agree to market eight products for treatment of ophthalmic pathologies in Russia

Antisense Therapeutics enrolls acromegalic patients in ATL1103 Phase II trial

Antisense Therapeutics enrolls acromegalic patients in ATL1103 Phase II trial

Occasional drinking and physically activity linked with reduced risk of developing visual impairment

Occasional drinking and physically activity linked with reduced risk of developing visual impairment

ThromboGenics receives IWT grant to study potential new biotherapeutics for DME

ThromboGenics receives IWT grant to study potential new biotherapeutics for DME

Eye health experts across Commonwealth join forces to combat avoidable blindness

Eye health experts across Commonwealth join forces to combat avoidable blindness

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

pSivida announces financial results for second quarter 2014

pSivida announces financial results for second quarter 2014

Trinidad and Tobago, Johns Hopkins Medicine celebrate achievements of Diabetes Outreach Program

Trinidad and Tobago, Johns Hopkins Medicine celebrate achievements of Diabetes Outreach Program

Research under way to develop new techniques for detecting diabetic retinopathy

Research under way to develop new techniques for detecting diabetic retinopathy

Study shows endoplasmic reticulum stress plays important role in diabetic retinopathy

Study shows endoplasmic reticulum stress plays important role in diabetic retinopathy

ANP reports positive interim results from ATL1103 Phase II clinical trial for acromegaly

ANP reports positive interim results from ATL1103 Phase II clinical trial for acromegaly

New optical device puts the power to detect retinal disease in the palm of a hand

New optical device puts the power to detect retinal disease in the palm of a hand

FDA accepts Regeneron's EYLEA Injection sBLA for standard review

FDA accepts Regeneron's EYLEA Injection sBLA for standard review

Patients who undergo gastric bypass less likely to have risk of heart attack and stroke

Patients who undergo gastric bypass less likely to have risk of heart attack and stroke

Gastric bypass dramatically improves multiple cardiovascular risk factors in the long term

Gastric bypass dramatically improves multiple cardiovascular risk factors in the long term

Endocrine Society publishes Clinical Practice Guideline on diabetes and pregnancy

Endocrine Society publishes Clinical Practice Guideline on diabetes and pregnancy

NEI-funded study explores methods to improve diagnosis, treatment of common eye diseases

NEI-funded study explores methods to improve diagnosis, treatment of common eye diseases

Promising technique for treating eye disease proves effective in preclinical studies

Promising technique for treating eye disease proves effective in preclinical studies

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

Allegro receives FDA IND approval to initiate Phase II clinical studies of ALG-1001 in AMD, VMT patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.